ADENURIC, known generically as febuxostat, is a medication primarily used in the management and treatment of chronic gout and hyperuricemia. It operates as a xanthine oxidase inhibitor, effectively reducing the production of uric acid in the body. By lowering uric acid levels, ADENURIC helps to prevent gout attacks, which are caused by the deposition of uric acid crystals in the joints, leading to inflammation and intense pain. It is an oral medication, making it convenient for patients to take as part of their daily regimen. ADENURIC is often prescribed when patients are intolerant or have contraindications to allopurinol, another commonly used gout medication. It is important for patients to follow their healthcare provider's instructions when taking ADENURIC to ensure its effectiveness and to minimize potential side effects.